Company intelligence / Profile preview

Totalbau Bioscience

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Totalbau Bioscience is an early-stage biotechnology company focused on the discovery and development of novel therapeutic agents. The company leverages its expertise in medicinal chemistry and molecular biology to target complex disease pathways in oncology and infectious diseases. Currently operating in the pre-clinical phase, Totalbau Bioscience aims to advance a pipeline of small molecule candidates toward clinical evaluation. The firm is characterized by its lean operational model and focus on high-impact research and development.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Totalbau Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Totalbau Bioscience.

Explore the full profile